Biotechnology Stocks II Performance Guide: Taysha Gene Therapies, Inc. (TSHA)
TSHA has no dividends.
Table and Chart of TSHA Performance
See what a $1,000 investment in TSHA is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| TSHA Returns | |
|---|---|
| Start Date | Oct-30-2020 |
| Start Price | $20.80 |
| End Date | Jul-26-2024 |
| End Price | $2.30 |
| # Prices | 46 |
| Min Date | Jun-30-2023 |
| Min Price | $0.66 |
| Max Date | Dec-31-2020 |
| Max Price | $26.54 |
| Total Return | -88.94% |
| Annualized Return | -43.70% |
| Current Value of $1,000 Purchase | $111 |
| Number Returns | 1,035 |
| Average Return | -34.23% |
| Number Profitable Returns | 186 |
| Percent Profitable Returns | 17.97% |
| Number Unprofitable Returns | 849 |
| Percent Unprofitable Returns | 82.03% |
| Profitable to Unprofitable Returns Ratio | 0.22 |
| TSHA Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $457,130,000 |
| Beta | 0.389 | Price to Sales | 35.59 |
| Earnings per Share | $-0.7800 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 7.32 |
| PRICE DATA | |
| 52 Week High | $4.32 |
| 52 Week Low | $0.647 |
| Analyst Target Price | $6.59 |
| 50-Day Moving Average | $2.878 |
| 200-Day Moving Average | $2.318 |
| FINANCIAL DATA | |
| Revenue per Share | $0.09 |
| Revenue | $14,156,000 |
| Profit Margin | 0% |
| Return on Equity | -607% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
TSHA Compare Returns with S&P 500
TSHA Trendline Chart
TSHA Moving Average Chart
TSHA Stock Return Map - See Patterns of Gains and Losses
TSHA Stock Returns/Purchase Dates